Delivery Order 36C25722D0051-36C25725N0202

Award Date 6/3/25
Potential Completion Date 6/2/26
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Chester, PA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) has awarded a $18,466.34 firm-fixed-price delivery order contract to Caredx Lab Solutions Inc., a subsidiary of Caredx, Inc., to provide AlloMap molecular testing services for heart transplant patient monitoring. This delivery order is placed against a single-award indefinite delivery contract (IDC) valued at $787,000 that Caredx Lab Solutions holds with the VA's Veterans Integrated Service Network 17 (VISN 17), which runs through June 2027. The contract...
This federal contract award is for "TRANSPLANT LABORATORY TESTING" services provided by Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services to support organ transplant programs. The contract, valued at $205,530.69, was awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9). The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract valued at...
This federal contract award, valued at $392,628.24, was issued by the Veterans Integrated Service Network 9 (VISN 9) of the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization that specializes in providing advanced medical testing products and services to support organ transplant programs. The contract covers the provision of Caredx's AlloMap and AlloSure genetic blood testing services for transplant patients. Caredx has a strong history of securing VA contracts for...
This federal contract award to Caredx, Inc., a for-profit medical testing company, is for the provision of specialized genetic testing services to support organ transplant programs for the U.S. Department of Veterans Affairs (VA). The contract, valued at $529,760.00, is a delivery order awarded under a larger Indefinite Delivery Vehicle (IDV) contract with a $1,963,141.20 ceiling for genetic blood testing services. Caredx will supply the VA with its AlloSure kidney and heart tests, AlloMap heart...
This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $244,800.00, is for laboratory tests and specialty transplant services. The contract is not set aside and was awarded under the VA's Veterans Integrated Service Network 9 (VISN 9) to Caredx, which has been awarded multiple indefinite...
This is a federal contract award to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $4,807,230.45, is for laboratory tests for post-transplant organ rejection and was awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of March 31, 2026....
This is a $245,479.74 firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract is for the provision of testing kits for post-transplant patients and does not have a set-aside designation. Caredx, headquartered in Brisbane, California, will provide specialized...
This is a federal contract awarded by the Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit organization specializing in advanced medical testing products and services focused on organ transplant diagnostics. The contract, valued at $412,217.17, is for HEART TRANSPLANT REJECTION TESTING services. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2022. The contract was awarded on September 1, 2016 and...
This federal contract award to Caredx, Inc., a for-profit organization headquartered in Brisbane, California, is for the provision of AlloMap gene testing services. The contract, valued at $158,760.00, was awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) and has an ultimate completion date of July 31, 2027. Caredx, a leading provider of specialized transplant diagnostic solutions, will deliver its AlloMap gene testing services...
Caredx Lab Solutions Inc. was awarded a firm fixed price delivery order against the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 indefinite delivery contract to provide AlloMap molecular testing services. The $6,480 order has a completion date of June 2, 2023 and was awarded on June 3, 2022 to support the VISN's care of veteran transplant recipients in the Dallas, Texas area. The single award IDC, which has a potential value of $675,000 and...
  • 36C25722D0051
    Indefinite Delivery Contract
  • 36C25722D0051-36C25725N0202
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Caredx Lab Solutions Inc., a for-profit manufacturer of genomics-based solutions for transplant patients. The $59,931.70 contract provides CAREDX ALLOMAP molecular testing services to support post-transplant surveillance and patient management for heart transplant recipients within the VA network. The contract is an indefinite delivery vehicle with a performance period running through June 2026. No set-aside designation was used, indicating Caredx competed based on its technical expertise in transplant-related molecular diagnostics. This award is part of a larger $787,000 single-award indefinite delivery contract Caredx holds with the VA, demonstrating the company's specialized capabilities in delivering FDA-approved AlloMap tests to help healthcare providers assess transplant rejection risks through advanced genomic testing.

Generated 2/11/25, 10:19 AM